Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Hypertension (Dallas, Tex. : 1979)|December 29, 2016
Effect of Uric Acid-Lowering Agents on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled TrialLea Borgi, Ciaran McMullan, Ann Wohlhueter, et al.American Journal of Hypertension|January 13, 2017
Effect of Vitamin D on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled TrialLea Borgi, Ciaran McMullan, Ann Wohlhueter, et al.Investigative Ophthalmology & Visual Science|April 24, 2009
Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implicationsVassiliki Poulaki, Constantine S Mitsiades, Vassiliki Kotoula, et al.The Journal of Clinical Endocrinology and Metabolism|September 13, 2007
Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibitionConstantine S Mitsiades, Patrick Hayden, Vassiliki Kotoula, et al.The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomasVassiliki Poulaki, Constantine S Mitsiades, Ciaran McMullan, et al.Clinical Journal of the American Society of Nephrology : CJASN|June 4, 2017
CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled TrialsSamir G Mallat, Bassem Y Tanios, Houssam S Itani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Novel histone deacetylase inhibitors in the treatment of thyroid cancerConstantine S Mitsiades, Vassiliki Poulaki, Ciaran McMullan, et al.Journal of Cardiac Failure|August 21, 2025
Characterizing real-world use of vericiguat in the USAlejandro Victores, Lori D Bash, Boshu Ru, et al.The Journal of Clinical Endocrinology and Metabolism|July 20, 2006
Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitroConstantine S Mitsiades, Douglas McMillin, Vassiliki Kotoula, et al.Molecular Cancer Therapeutics|March 17, 2007
Targeting BRAFV600E in thyroid carcinoma: therapeutic implicationsConstantine S Mitsiades, Joseph Negri, Ciaran McMullan, et al.Pageof 2